Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Dec 03, 2024$90.47
P/E Ratio
74.80
Market Cap
$133.28B
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Overview
Trading Information
Company